General Information
BounceWatch is an independent company data service, not affiliated with Kanyos Bio. To contact Kanyos Bio, visit kanyos.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Kanyos Bio compare?
A PDF of Kanyos Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Kanyos Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Kanyos Bio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Kanyos Bio
Business keywords: Antigen-specific immune tolerance technology, Autoimmune indications, Type-1 diabetes, Celiac disease, EPFL, Anokion, Immunotechnology expertise, Clinical translation, Astellas Pharma, Therapies, Disease-modifying, Switzerland, Research and development, Healthcare innovation
Funding Rounds & Investors (2)
View AllKanyos Bio Alternatives & Competitors
View All AlternativesDevelops drugs for treatments of allergic diseases
Innovative therapies for autoimmune diseases through targeted immune-regulation using proprietary na...
Pioneering safe and effective treatments for autoimmune lung diseases through groundbreaking discove...
FAQ About Kanyos Bio
Source: BounceWatch company record for Kanyos Bio, https://bouncewatch.com/company/kanyos-bio, updated 10 October 2024. When citing, please name BounceWatch and link this page.